GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Tiantan Biological Products Corp Ltd (SHSE:600161) » Definitions » Other Current Receivables

Beijing Tiantan Biological Products (SHSE:600161) Other Current Receivables : ¥126 Mil (As of Mar. 2024)


View and export this data going back to 1998. Start your Free Trial

What is Beijing Tiantan Biological Products Other Current Receivables?

Beijing Tiantan Biological Products's Other Current Receivables for the quarter that ended in Mar. 2024 was ¥126 Mil.

Beijing Tiantan Biological Products's quarterly Other Current Receivables declined from Sep. 2023 (¥497.64 Mil) to Dec. 2023 (¥115.34 Mil) but then increased from Dec. 2023 (¥115.34 Mil) to Mar. 2024 (¥126.11 Mil).

Beijing Tiantan Biological Products's annual Other Current Receivables increased from Dec. 2021 (¥1,039.75 Mil) to Dec. 2022 (¥1,167.67 Mil) but then declined from Dec. 2022 (¥1,167.67 Mil) to Dec. 2023 (¥115.34 Mil).


Beijing Tiantan Biological Products Other Current Receivables Historical Data

The historical data trend for Beijing Tiantan Biological Products's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Tiantan Biological Products Other Current Receivables Chart

Beijing Tiantan Biological Products Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 650.23 697.99 1,039.75 1,167.67 115.34

Beijing Tiantan Biological Products Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,108.68 915.84 497.64 115.34 126.11

Beijing Tiantan Biological Products Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.


Beijing Tiantan Biological Products Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Beijing Tiantan Biological Products's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Tiantan Biological Products (SHSE:600161) Business Description

Traded in Other Exchanges
N/A
Address
No. 4 Sanjianfang South Li, Zhongdan Center, Beijing, CHN, 100024
Beijing Tiantan Biological Products Corp Ltd is a China-based company engaged in the research and development, manufacturing, sales and consulting services for blood products. The company's blood products include Shanghai Blood Human Albumin, Shanghai blood system intravenous injection of human immunoglobulin, Guizhou blood human albumin, Rongsheng human albumin, Guizhou blood system static injection immunoglobulin, Rongsheng tetanus human immunoglobulin and others.
Executives
Wang Jian Ming Supervisors
Liu Ya Na Directors, senior managers
Fu Dao Xing Directors, senior managers
He Yan Lin Directors, senior managers
Hu Li Gang Director
Ci Xiang senior management
Yang Hui Chuan Director
Zhang Yi senior management
Wu Zhen Shan senior management

Beijing Tiantan Biological Products (SHSE:600161) Headlines

No Headlines